Efficacy of various doses and schedules of second-generation tyrosine kinase inhibitors.

Bixby, Dale L

Efficacy of various doses and schedules of second-generation tyrosine kinase inhibitors. [electronic resource] - Clinical lymphoma & myeloma Mar 2008 - S95-S106 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1557-9190

10.3816/CLM.2008.s.005 doi


Benzamides
Clinical Trials as Topic
Dasatinib
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Piperazines--administration & dosage
Protein Kinase Inhibitors--administration & dosage
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrimidines--administration & dosage
Thiazoles--administration & dosage
Treatment Outcome